cas 1286207-68-8|| where to buy (R)-(3-Aminopyrrolidin-1-yl)(cyclopropyl)methanone hydrochloride

Nom du produit:(R)-(3-Aminopyrrolidin-1-yl)(cyclopropyl)methanone hydrochloride

IUPAC Name:(3R)-1-cyclopropanecarbonylpyrrolidin-3-amine hydrochloride

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM248693-250mg	in stock	Ǌů

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1286207-68-8 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1286207-68-8; Formule moléculaire:C8H15ClN2O; Point de fusion:-; Code SMILES:O=C(N1C[C@H](N)CC1)C2CC2.[H]Cl; Densité:

: Numéro de catalogue:CM248693; Poids moléculaire:190.67; Point d'ébullition:; N° Mdl:MFCD17014275; Stockage:Keep in inert atmosphere, store at 2-8°C.

: Pyrrolidines; Pyrrolidine, also known as tetrahydropyrrole, is a saturated five-membered heterocyclic ring, which is miscible with water. Pyrrolidine exists in many alkaloids and drug molecules, such as kappa opioids, antagonists of dopamine D4 receptors, and HIV reverse transcriptase inhibitors.

: Cyclopropanes; Cyclopropane is the smallest cyclic compound with unique structural features and physicochemical properties, which is widely used in the design of small molecule drugs. In drug design, it is often used to increase activity, fix conformation and improve PK and water solubility. The introduction of cyclopropyl groups into drugs can change various properties of molecules, such as improving metabolic stability; increasing biological activity; enhancing drug efficacy; limiting polypeptide conformation and slowing down its hydrolysis; reducing plasma clearance; improving drug dissociation and many more. Cyclopropane rings are widely found in marketed drugs, including cardiovascular drugs, central nervous system (CNS) drugs, anticancer drugs, autoimmune and anti-inflammatory drugs.